Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab

Bibliographic Details
Main Authors: Pooja Virmani, MBBS, Klaus Busam, MD, Patricia L. Myskowski, MD, Amy Yang, MD, Cynthia Magro, MD, Steven Horwitz, MD
Format: Article
Language:English
Published: Elsevier 2017-07-01
Series:JAAD Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512617300644
_version_ 1828879388412739584
author Pooja Virmani, MBBS
Klaus Busam, MD
Patricia L. Myskowski, MD
Amy Yang, MD
Cynthia Magro, MD
Steven Horwitz, MD
author_facet Pooja Virmani, MBBS
Klaus Busam, MD
Patricia L. Myskowski, MD
Amy Yang, MD
Cynthia Magro, MD
Steven Horwitz, MD
author_sort Pooja Virmani, MBBS
collection DOAJ
first_indexed 2024-12-13T09:27:29Z
format Article
id doaj.art-dba009e6abeb4bf2a5ba4b4bbb901d9e
institution Directory Open Access Journal
issn 2352-5126
language English
last_indexed 2024-12-13T09:27:29Z
publishDate 2017-07-01
publisher Elsevier
record_format Article
series JAAD Case Reports
spelling doaj.art-dba009e6abeb4bf2a5ba4b4bbb901d9e2022-12-21T23:52:36ZengElsevierJAAD Case Reports2352-51262017-07-013426927210.1016/j.jdcr.2017.02.024Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximabPooja Virmani, MBBS0Klaus Busam, MD1Patricia L. Myskowski, MD2Amy Yang, MD3Cynthia Magro, MD4Steven Horwitz, MD5Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New YorkDepartment of Pathology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New YorkDepartment of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New YorkDepartment of Dermatopathology, West Dermatology, Placentia, CaliforniaDepartment of Pathology, Weill Cornell Medical College, New York, New YorkDepartment of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New Yorkhttp://www.sciencedirect.com/science/article/pii/S2352512617300644central nervous systemcutaneous B-cell lymphomaleptomeningeal involvementprimary cutaneous marginal zone lymphomarituximab
spellingShingle Pooja Virmani, MBBS
Klaus Busam, MD
Patricia L. Myskowski, MD
Amy Yang, MD
Cynthia Magro, MD
Steven Horwitz, MD
Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab
JAAD Case Reports
central nervous system
cutaneous B-cell lymphoma
leptomeningeal involvement
primary cutaneous marginal zone lymphoma
rituximab
title Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab
title_full Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab
title_fullStr Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab
title_full_unstemmed Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab
title_short Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab
title_sort primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab
topic central nervous system
cutaneous B-cell lymphoma
leptomeningeal involvement
primary cutaneous marginal zone lymphoma
rituximab
url http://www.sciencedirect.com/science/article/pii/S2352512617300644
work_keys_str_mv AT poojavirmanimbbs primarycutaneousmarginalzonelymphomawithleptomeningealinvolvementandadurableresponsetorituximab
AT klausbusammd primarycutaneousmarginalzonelymphomawithleptomeningealinvolvementandadurableresponsetorituximab
AT patricialmyskowskimd primarycutaneousmarginalzonelymphomawithleptomeningealinvolvementandadurableresponsetorituximab
AT amyyangmd primarycutaneousmarginalzonelymphomawithleptomeningealinvolvementandadurableresponsetorituximab
AT cynthiamagromd primarycutaneousmarginalzonelymphomawithleptomeningealinvolvementandadurableresponsetorituximab
AT stevenhorwitzmd primarycutaneousmarginalzonelymphomawithleptomeningealinvolvementandadurableresponsetorituximab